Industry

CARVYKTI® is Legend Biotech’s first European Commission-approved product The approval is based on the pivotal phase 1b/2 CARTITUDE-1 study, which demonstrated an overall response rate (ORR) of 98 percent in patients with relapsed or refractory multiple myeloma following a one-time treatment with ciltacabtagene autoleucel SOMERSET, N.J.–(BUSINESS WIRE)–$LEGN–Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global … [Read more…]

SEATTLE–(BUSINESS WIRE)–#EHR—Health and Social Care Northern Ireland (HSCNI) has enlisted the support of global healthcare technology specialist, Tegria, and digital health consultancy, Cloud21, in a deal to support its national digital transformation programme. The organisations will help to deliver Northern Ireland’s Encompass programme – a decade long initiative that aims to deliver improvements to outcomes … [Read more…]

In the pivotal clinical study CARTITUDE-1, 98 percent of patients with relapsed or refractory multiple myeloma responded to a one-time treatment with ciltacabtagene autoleucel and 80 percent of patients who responded experienced a stringent complete response1 BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission (EC) granted conditional … [Read more…]

DAVIS, Calif.–(BUSINESS WIRE)–Please replace the caption with the accompanying correct caption. The release reads: BSI WINS BEST BIOTECH STARTUP BUSINESS OF THE YEAR 2022 AWARD Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials (ABM) for agricultural and pharmaceutical applications, has won the “Best Biotech Startup Business of the Year 2022” … [Read more…]

Partnership agreement signed with Midnight Health to deliver a world-first personalised consumer health service called Vidality Midnight Health will promote, market and sell a new subscription consumer health service driven by Microba’s core technology nib-backed (ASX: NHF) Midnight Health is a fast growth, Australian-based, digital healthcare company BRISBANE, Australia–(BUSINESS WIRE)–$MAP—Microba Life Sciences Limited (ASX: MAP) … [Read more…]

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969) announced today that it has received approval to conduct a single-arm, open-label, multicenter phase II clinical trial evaluating the safety and efficacy of tafasitamab in combination with lenalidomide by China’s National Medical Products Administration (NMPA) for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) … [Read more…]

Consultation and resources available at no cost to Superior HealthPlan members and local community FRISCO, Texas–(BUSINESS WIRE)–Magellan Health, Inc. today announced that it has opened a complimentary 24-hour crisis line for individuals impacted by the elementary school shooting that occurred in Uvalde, Texas on Tuesday. The line is available to all Superior HealthPlan members and … [Read more…]

BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is pleased to announce the closing of the first tranche of a Private Placement. The tranche consists of 506,157 Common Share Units at a price of $0.30 per Unit for net proceeds to the Company … [Read more…]

DAVIS, Calif.–(BUSINESS WIRE)–Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials (ABM) for agricultural and pharmaceutical applications, has won the “Best Biotech Startup Business of the Year 2022” Award from the World BioProtection Forum and was selected finalist for two more categories. This Award was presented to BSI Senior Vice President … [Read more…]

KIGALI, Rwanda–(BUSINESS WIRE)–#AHFRwanda–AIDS Healthcare Foundation (AHF) Rwanda, today reinforced its commitment to promoting access to healthcare services in the country through a two-part donation to the government’s Community-Based Health Insurance (CBHI) scheme. The first tranche of 133,866,000 RFW will support CBHI for 10,822 households with 44,622 beneficiaries, while the second tranche of 22,291,00 RWF will … [Read more…]